+

WO2010096564A4 - Compléments alimentaires contenant des acides gras oméga-3 polyinsaturés et des bactéries probiotiques avec bénéfices gastro-intestinaux et dermatologiques potentiels - Google Patents

Compléments alimentaires contenant des acides gras oméga-3 polyinsaturés et des bactéries probiotiques avec bénéfices gastro-intestinaux et dermatologiques potentiels Download PDF

Info

Publication number
WO2010096564A4
WO2010096564A4 PCT/US2010/024594 US2010024594W WO2010096564A4 WO 2010096564 A4 WO2010096564 A4 WO 2010096564A4 US 2010024594 W US2010024594 W US 2010024594W WO 2010096564 A4 WO2010096564 A4 WO 2010096564A4
Authority
WO
WIPO (PCT)
Prior art keywords
supplement
fatty acids
per gram
polyunsaturated fatty
probiotic bacteria
Prior art date
Application number
PCT/US2010/024594
Other languages
English (en)
Other versions
WO2010096564A3 (fr
WO2010096564A2 (fr
Inventor
Yoshiteru Koide
Original Assignee
Probiohealth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiohealth Llc filed Critical Probiohealth Llc
Publication of WO2010096564A2 publication Critical patent/WO2010096564A2/fr
Publication of WO2010096564A3 publication Critical patent/WO2010096564A3/fr
Publication of WO2010096564A4 publication Critical patent/WO2010096564A4/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention porte sur une nouvelle famille de compléments alimentaires contenant des acides gras polyinsaturés, une culture probiotique et facultativement du collagène hydrolysé. Le complément prototype contient de l'huile de graines de canneberges en tant que source d'acides gras oméga 3 et oméga 6, conjointement avec de la vitamine E. Le complément prototype contient également une souche spéciale de Lactobacillus casei ainsi que du collagène de poisson. Les compléments nutritionnels de cette invention peuvent être fournis sous forme de gélule ou de comprimé, ou sous forme d'articles alimentaires tels que des confiseries à base de chocolat. Chacun des trois ingrédients confère un bénéfice propre, permettant au consommateur d'obtenir trois compléments alimentaires avec la commodité d'un seul produit. Les ingrédients sont également pensés fonctionner de manière synergique pour obtenir un effet global plus important et plus durable. Dans des essais cliniques humains, la consommation du complément alimentaire a été associée à des observations subjectives d'amélioration de la douceur et de l'hydratation de la peau du visage, la réduction des rides, et l'amélioration de la fonction du tractus gastro-intestinal.
PCT/US2010/024594 2009-02-19 2010-02-18 Compléments alimentaires contenant des acides gras oméga-3 polyinsaturés et des bactéries probiotiques avec bénéfices gastro-intestinaux et dermatologiques potentiels WO2010096564A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20815009P 2009-02-19 2009-02-19
US61/208,150 2009-02-19

Publications (3)

Publication Number Publication Date
WO2010096564A2 WO2010096564A2 (fr) 2010-08-26
WO2010096564A3 WO2010096564A3 (fr) 2011-04-07
WO2010096564A4 true WO2010096564A4 (fr) 2011-07-14

Family

ID=42634439

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/024594 WO2010096564A2 (fr) 2009-02-19 2010-02-18 Compléments alimentaires contenant des acides gras oméga-3 polyinsaturés et des bactéries probiotiques avec bénéfices gastro-intestinaux et dermatologiques potentiels

Country Status (1)

Country Link
WO (1) WO2010096564A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2603208T3 (da) 2010-08-10 2014-09-15 Rp Scherer Technologies Llc Fremgangsmåde til fremstilling af en stabil softgelkapsel indeholdende mikroindkapslede probiotiske bakterier
FR2973650A1 (fr) * 2011-04-08 2012-10-12 Frederic Pottecher Moyens pour masquer le gout et l'odeur d'hydrolysats peptidiques
EP2710901A1 (fr) * 2012-09-20 2014-03-26 Symrise AG Composition de supplément diététique
FI20126389L (fi) * 2012-12-28 2014-06-29 Aromtech Ltd Kapseli ja siemenöljyä käsittävä koostumus
US9211277B2 (en) 2013-02-07 2015-12-15 Young Living Essential Oils, Lc Dietary supplement composition
EP3595695A1 (fr) * 2017-03-15 2020-01-22 Rousselot B.V. Compositions de peptides de collagène hydrolysé et de micro-organismes commensaux et leurs procédés
US11896720B2 (en) * 2017-09-26 2024-02-13 Captek Softgel International Orally available articles containing at least one stabilized supplement therein
WO2020018504A1 (fr) * 2018-07-16 2020-01-23 Lonza Inc. Supplément de collagène et de matière cellulaire et son procédé d'administration
IT201900008394A1 (it) * 2019-06-07 2020-12-07 Sofar Spa Composizione per uso nel trattamento delle malattie infiammatorie croniche intestinali
WO2024144735A1 (fr) * 2022-12-28 2024-07-04 Chivalric Regulus Biyoteknoloji Anonim Sirketi Complément alimentaire microencapsulé contenant des micro-organismes probiotiques
WO2024167478A1 (fr) * 2023-02-06 2024-08-15 Toplu Celal Chocolat, gaufrette, gaufrette au tahini, biscuit à la crème et biscuit à la crème au tahini enrichis en acide alpha-linolénique oméga-3 essentiel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009160A1 (en) * 2001-06-22 2004-01-15 Villamar Daniel F Bioactive food complex, method for making bioactive food complex product and method for controlling disease
DK1992351T3 (en) * 2007-05-18 2016-06-06 Nestec Sa Lactobacillus johnsonii for the prevention of post-surgical infection
EP2173856A1 (fr) * 2007-06-28 2010-04-14 Chr. Hansen A/S Traitement de suspension de cellules
MX2010001260A (es) * 2007-08-03 2010-04-07 Shaklee Corp Sistema de suplemento nutricional.

Also Published As

Publication number Publication date
WO2010096564A3 (fr) 2011-04-07
WO2010096564A2 (fr) 2010-08-26

Similar Documents

Publication Publication Date Title
WO2010096564A4 (fr) Compléments alimentaires contenant des acides gras oméga-3 polyinsaturés et des bactéries probiotiques avec bénéfices gastro-intestinaux et dermatologiques potentiels
Liang et al. Current microalgal health food R & D activities in China
EP1871485B1 (fr) Utilisation d'un complement alimentaire administre par voie orale pour reguler l'aspect cosmetique du tissu keratineux humain
JPWO2017130859A1 (ja) 神経細胞死抑制剤
CN104822363B (zh) 至少一种多不饱和脂肪酸和至少一种类胡萝卜素的组合用于改善指甲品质的用途
CA2994347A1 (fr) Procedes et compositions utilisant du bifidobacterium longum pour moduler une reactivite emotionnelle et traiter ou prevenir des troubles de l'humeur subcliniques
EP2520177B1 (fr) Compositions nutritionnelles comprenant des flocons de fruits contenant de l'acide docosahexénoïque
JP5594819B2 (ja) 脂質代謝改善用組成物
WO2008059965A1 (fr) Agent pour soulager ou prévenir des symptômes de stress et agent pour améliorer des états mentaux
Chávarri et al. The role of probiotics in nutritional health: Probiotics as nutribiotics
WO2018225786A1 (fr) Composition pour l'activation de l'immunité cellulaire
MX2013005025A (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
CN101449824A (zh) 蓝莓刺玫果蜂花粉食品
MX355787B (es) Cepas de lactococcus lactis y preparaciones bacterianas de las mismas, para la producción de péptidos bioactivos que tienen efectos antihipertensivos y de disminución de colesterol en mamíferos; productos nutricionales y terapéuticos producidos a partir de los mismos.
JP5048246B2 (ja) スキンケア用の内服組成物
JP7231898B2 (ja) 睡眠の質改善剤
WO2021053447A1 (fr) Supplément nutritionnel pour patients atteints d'un cancer
Rao et al. A review on dietary supplements: Delivery systems, applications and regulations
JP2019081733A5 (fr)
Mondal et al. Navigating the frontiers of mineral absorption in the human body: Exploring the impact of probiotic innovations: Impact of probiotics in mineral absorption by human body
RU2790676C1 (ru) Пробиотическая композиция на растительном сырье и способ её получения
JP6049108B2 (ja) 覚醒時間延長剤
JP2024038951A (ja) Akkermansia属細菌増殖促進剤
PH12012000351A1 (en) Whitening supplement with probiotics
WO2023079036A1 (fr) Composition probiotique comprenant une souche de lactobacillus salivarius, une souche de lactobacillus camelliae et une souche de bifidobacterium ruminantium

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10744298

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 10744298

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载